Engineers Gate Manager’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $712K | Buy |
124,769
+9,970
| +9% | +$45.3K | 0.01% | 1278 |
|
|
2026
Q1 | $517K | Buy |
114,799
+50,257
| +78% | +$262K | 0.01% | 1401 |
|
|
2025
Q4 | $397K | Sell |
64,542
-34,706
| -35% | -$252K | ﹤0.01% | 1477 |
|
|
2025
Q3 | $718K | Buy |
99,248
+20,421
| +26% | +$121K | 0.01% | 1329 |
|
|
2025
Q2 | $419K | Sell |
78,827
-13,779
| -15% | -$81.4K | 0.01% | 1562 |
|
|
2025
Q1 | $821K | Sell |
92,606
-9,908
| -10% | -$119K | 0.01% | 1178 |
|
|
2024
Q4 | $1.41M | Buy |
102,514
+67,670
| +194% | +$1.25M | 0.02% | 804 |
|
|
2024
Q3 | $954K | Buy |
34,844
+10,714
| +44% | +$290K | 0.02% | 1018 |
|
|
2024
Q2 | $590K | Buy |
+24,130
| New | +$529K | 0.01% | 1148 |
|
|
2024
Q1 | – | Sell |
-45,146
| Closed | -$864K | – | 2166 |
|
|
2023
Q4 | $864K | Buy |
45,146
+26,471
| +142% | +$458K | 0.02% | 876 |
|
|
2023
Q3 | $300K | Buy |
18,675
+4,734
| +34% | +$90.1K | 0.01% | 1321 |
|
|
2023
Q2 | $323K | Buy |
+13,941
| New | +$304K | 0.01% | 1275 |
|
|
2022
Q4 | – | Sell |
-26,093
| Closed | -$498K | – | 1909 |
|
|
2022
Q3 | $498K | Sell |
26,093
-124,735
| -83% | -$2.86M | 0.03% | 817 |
|
|
2022
Q2 | $2.74M | Buy |
150,828
+136,554
| +957% | +$2.84M | 0.1% | 259 |
|
|
2022
Q1 | $360K | Buy |
+14,274
| New | +$365K | 0.01% | 1274 |
|
|
2021
Q4 | – | Sell |
-48,153
| Closed | -$1.55M | – | 2198 |
|
|
2021
Q3 | $1.55M | Buy |
+48,153
| New | +$1.6M | 0.09% | 308 |
|
|
2020
Q4 | – | Sell |
-93,912
| Closed | -$1.23M | – | 1879 |
|
|
2020
Q3 | $1.23M | Sell |
93,912
-126,010
| -57% | -$1.59M | 0.06% | 511 |
|
|
2020
Q2 | $2.49M | Buy |
+219,922
| New | +$3.12M | 0.13% | 203 |
|
|
2020
Q1 | – | Sell |
-100,953
| Closed | -$2.75M | – | 1806 |
|
|
2019
Q4 | $2.75M | Buy |
+100,953
| New | +$2.78M | 0.12% | 244 |
|
|
2019
Q3 | – | Sell |
-120,290
| Closed | -$3.34M | – | 1530 |
|
|
2019
Q2 | $3.34M | Buy |
120,290
+32,450
| +37% | +$916K | 0.18% | 160 |
|
|
2019
Q1 | $2.92M | Buy |
+87,840
| New | +$2.67M | 0.18% | 179 |
|
|
2018
Q1 | – | Sell |
-21,533
| Closed | -$740K | – | 919 |
|
|
2017
Q4 | $740K | Buy |
+21,533
| New | +$726K | 0.05% | 526 |
|
|
2017
Q3 | – | Sell |
-56,841
| Closed | -$1.47M | – | 777 |
|
|
2017
Q2 | $1.47M | Buy |
56,841
+23,491
| +70% | +$499K | 0.13% | 290 |
|
|
2017
Q1 | $640K | Buy |
+33,350
| New | +$591K | 0.06% | 410 |
|
|
2016
Q3 | – | Sell |
-63,100
| Closed | -$1.93M | – | 706 |
|
|
2016
Q2 | $1.93M | Buy |
+63,100
| New | +$2.19M | 0.14% | 280 |
|
|
2016
Q1 | – | Sell |
-10,951
| Closed | -$473K | – | 777 |
|
|
2015
Q4 | $473K | Buy |
+10,951
| New | +$463K | 0.03% | 511 |
|
Other funds holding MYGN
VPC
Engineers Gate Manager's MYGN Position: Q2 2026 in Review
Engineers Gate Manager increased its Myriad Genetics (MYGN) stake by 8.7% in Q2 2026, buying an estimated $45.3K and bringing the position to 124,769 shares worth $712K. The position accounts for 0.01% of the portfolio, ranked #1278.
Engineers Gate Manager first reported a position in MYGN in Q4 2015 and has held it in 26 quarters since. The position peaked at $3.34M in Q2 2019. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Engineers Gate Manager held 124,769 shares of Myriad Genetics worth $712K as of Q2 2026.
- Engineers Gate Manager bought 9,970 Myriad Genetics shares in Q2 2026, an estimated $45.3K.
- Myriad Genetics made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1278 holding.
- Engineers Gate Manager first reported a position in Myriad Genetics in Q4 2015 and has held it in 26 quarters since.
- Engineers Gate Manager's Myriad Genetics position peaked at $3.34M in Q2 2019.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.